| Literature DB >> 28092803 |
Jane Willoughby1, Jordana Griffiths2, Ivo Tews3, Mark S Cragg4.
Abstract
OX40 is a type 1 transmembrane glycoprotein, reported nearly 30 years ago as a cell surface antigen expressed on activated T cells. Since its discovery, it has been validated as a bone fide costimulatory molecule for T cells and member of the TNF receptor family. However, many questions still remain relating to its function on different T cell sub-sets and with recent interest in its utility as a target for antibody-mediated immunotherapy, there is a growing need to gain a better understanding of its biology. Here, we review the expression pattern of OX40 and its ligand, discuss the structure of the receptor:ligand interaction, the downstream signalling it can elicit, its function on different T cell subsets and how antibodies might engage with it to provide effective immunotherapy.Entities:
Keywords: Immunotherapy; Monoclonal antibody; OX40; OX40L; Tnfr; Treg
Mesh:
Substances:
Year: 2017 PMID: 28092803 DOI: 10.1016/j.molimm.2017.01.006
Source DB: PubMed Journal: Mol Immunol ISSN: 0161-5890 Impact factor: 4.407